Diclofenac Sodium
Product Images NDC 61919-468

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Diclofenac Sodium (NDC 61919-468). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Direct Rx, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Image Description (Label)

Image Description (Label)
This is a medication called Diclofenac Sodium E/R. It comes in a dose of 100mg and a package size of 30 tablets. The label warns that it may cause drowsiness.*
FDA Label Image

Image Description (Sideeffects)

Image Description (Sideeffects)
This appears to be a list of potential side effects that can occur when taking certain medications. It includes serious conditions such as heart attack, stroke, and high blood pressure, as well as other side effects like stomach pain, constipation, diarrhea, and gas. Kidney problems, bleeding and ulcers in the stomach and intestine, and anemia are also included. In some cases, life-threatening skin reactions, allergic reactions, and liver failure may occur. The list mentions that people with asthma may experience asthma attacks when taking certain medications.*
FDA Label Image

Image Description (Structure)

Image Description (Structure)
This text is not readable and appears to be a collection of chemical symbols or formulas. Therefore, it is not possible to generate a useful description.*
FDA Label Image

Image Description (Warning)

Image Description (Warning)
This text discusses the risks associated with using NSAIDs such as Diclofenac Sodium Extended-release Tablets, USP. It highlights the increased risk of serious cardiovascular thrombotic events, myocardial infarction, and stroke which can be fatal, especially among patients with cardiovascular disease or risk factors for it. It also mentions that NSAIDs can cause serious gastrointestinal adverse events, including inflammation, bleeding, ulceration, and perforation of the stomach or intestines, which can also be fatal, with elderly patients at a higher risk. The use of Diclofenac Sodium Extended-release Tablets, USP is not recommended for peri-operative pain in the setting of CABG surgery.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.